May 25, 2011
AstraZeneca Pharmaceuticals LP hit Intellipharmaceutics Corp. with a suit Monday in New Jersey federal court, adding the company to the list of generic-drug makers accused of infringing a patent for schizophrenia and bipolar drug Seroquel XR.